The Global Heart Defect Closure Device Market Is Projected To Grow At A Steady 12.9% CAGR Between 2026 And 2030

 The Business Research Company’s 2026 market reports incorporate enhanced features, including market attractiveness scoring and analysis, total addressable market evaluation, a company scoring matrix, an interactive Excel data dashboard, refined supply chain analysis, insights on emerging startups, and overviews of key products, all aimed at improving the depth, usability, and strategic relevance of the insights delivered.

 
 What Market Value Is The Heart Defect Closure Device Market Likely To Achieve By 2030?
 The heart defect closure device market size has grown rapidly in recent years. It will grow from $1.27 billion in 2025 to $1.45 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing prevalence of congenital heart defects, advancements in interventional cardiology, growing awareness of septal defect treatments, expansion of cardiac catheterization labs, rising demand for minimally invasive cardiac procedure.
 
 The heart defect closure device market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growing elderly and pediatric patient population with structural heart defects, rising adoption of transcatheter cardiac interventions, increasing healthcare expenditure on cardiovascular care, expansion of specialized cardiac centers, growing focus on early diagnosis and treatment of heart defects. Major trends in the forecast period include rising adoption of minimally invasive transcatheter closure procedures, growing use of nitinol-based and self-expanding closure devices, increasing preference for device-based alternatives to open-heart surgery, expansion of structural heart disease treatment programs, rising focus on improved safety, efficacy, and long-term outcomes.
 
 Download Your Free Report Sample:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp&utm_source=Blogger&utm_medium=Paid&utm_campaign=Jul_PR
 
 What Are The Major Drivers Supporting The Heart Defect Closure Device Market Growth? 
 The growing number of people with congenital heart problems is expected to propel the growth of the heart defect closure device market going forward. Congenital heart problems refer to structural defects in the heart that are present at birth. The increase in congenital heart problems is due to genetic predispositions, environmental influences, and maternal health issues such as diabetes, obesity, and exposure to certain medications or infections during pregnancy. Heart defect closure devices help to treat congenital heart problems by offering minimally invasive solutions to seal abnormal heart openings, thus restoring normal blood flow, reducing complications, and improving overall cardiac function. For instance, in August 2025, according to the National Center for Biotechnology Information, a US-based governmental agency, between 2025 and 2050, cardiovascular disease is projected to rise significantly, with prevalence increasing by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, leading to an estimated 35.6 million cardiovascular deaths in 2050, up from 20.5 million in 2025. Therefore, the growing number of people with congenital heart problems is driving the heart defect closure device market.
 
 Which Emerging Companies Are Leading In The Heart Defect Closure Device Market?
 The heart defect closure device market covered in this report is segmented — 
 
 1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
 2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
 3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
 4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
 
 Subsegments:
 1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices 
 2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices 
 3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders 
 4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders 
 5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders
 
 Which Emerging Trends Are Driving Changes In The Heart Defect Closure Device Market?
 Major companies in the heart defect closure device market are advancing technologies such as device tracking tools to enhance procedural precision and clinician confidence. A device tracking tool is a system that provides real-time visualization of the position and movement of medical devices during treatment. For instance, in November 2025, Philips, a Netherlands-based health technology company, introduced DeviceGuide — an AI-driven tracking solution designed to support clinicians during complex minimally invasive heart valve repair procedures, especially for mitral valve regurgitation. Integrated with the EchoNavigator platform, DeviceGuide merges live X-ray and ultrasound imaging to generate a real-time 3D model of the repair device within the beating heart, improving visualization, orientation, and accuracy. Developed in collaboration with Edwards Lifesciences, the system streamlines workflows, enhances team coordination, and supports broader access to advanced cardiac interventions worldwide. 
 
 What Are The Major Segment Classifications In The Heart Defect Closure Device Market?
 The heart defect closure device market covered in this report is segmented — 
 
 1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
 2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
 3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
 4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
 
 Subsegments:
 1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices 
 2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices 
 3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders 
 4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders 
 5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders
 
 Explore the Complete Heart Defect Closure Device Market Report:
 https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report?utm_source=Free PR&utm_medium=Paid&utm_campaign=Jul_PR
 
 Which Regions Contribute The Highest Demand In The Heart Defect Closure Device Market?
 North America was the largest region in the heart defect closure device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 #Contact Us:#
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 #Follow Us On:#
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company